Cardiff Oncology, Inc.CRDFNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+9.2%
5Y CAGR+25.8%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+9.2%/yr
vs +35.0%/yr prior
5Y CAGR
+25.8%/yr
Recent deceleration
Acceleration
-25.8pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$35.33M-4.1%
2024$36.85M+12.2%
2023$32.86M+21.2%
2022$27.11M+56.0%
2021$17.38M+54.7%
2020$11.23M+0.7%
2019$11.16M+36.7%
2018$8.16M+3.6%
2017$7.88M-47.5%
2016$15.01M-